Sociodemographic and Clinical Determinants of Quality of Life of Patients with Non-small Cell Lung Cancer

  • Mariusz ChabowskiEmail author
  • Jacek Polański
  • Grzegorz Mazur
  • Dariusz Janczak
  • Joanna Rosińczuk
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1022)


Non-small cell lung cancer (NSCLC) is a serious health problem. Identifying factors affecting quality of life (QoL) may help modify risk factors and improve survival. The study included 180 patients treated for NSCLC in the Lower Silesian Center of Lung Diseases between January and December 2015. QoL was assessed with QLQ-C30 and QLQ-LC13 scales. General physical functioning was measured with the ECOG Performance Status scale. The clinical and sociodemographic data were retrieved from medical records. The influence of clinical and sociodemographic factors on QoL was examined. NSCLC reduced the global QoL (47.1 ± 23.4) and emotional functioning (57.8 ± 28.8); cognitive functioning was affected in least (76.0 ± 21.0). The patients reported fatigue (42.2 ± 26.2), sleep problems (42.0 ± 30.8), cough (49.8 ± 24.0), and taking analgesics (50.3 ± 37.1) as the most limiting factors. The worsening of a health condition expressed by the length of malignant disease; the presence of comorbidities, metastases, the cluster of symptoms, worse spirometric indices, and living alone had a negative influence on QoL. In conclusion, patients with NSCLC experience reduced QoL and emotional functioning. Proper treatment of comorbidities and symptom management may improve QoL in these patients.


Cognitive functioning NSCLC Performance status Physical functioning Quality of life Socioeconomic factors 


Conflict of Interests

The authors declare no conflicts of interest in relation to this article.


  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleischman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMedGoogle Scholar
  2. Arraras JI, Hernandez B, Martinez M, Cambra C, Rico M, Illarramendi JJ, Viudez A, Ibanez B, Zarandona U, Martinez E, Vera R (2016) Quality of life in Spanish advanced non-small-cell lung cancer patients: determinants of global QL and survival analyses. SpringerPlus 5:836CrossRefPubMedPubMedCentralGoogle Scholar
  3. Bendixen M, Jorgensen OD, Kronborg C, Andersen C, Licht PB (2016) Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. Lancet Oncol 17(6):836–844CrossRefPubMedGoogle Scholar
  4. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A(5):635–642CrossRefPubMedGoogle Scholar
  5. Braun DP, Gupta D, Staren ED (2011) Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer 11:353CrossRefPubMedPubMedCentralGoogle Scholar
  6. Brown DJ, McMillan DC, Milroy R (2005) The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 103(2):377–382CrossRefPubMedGoogle Scholar
  7. Corre R, Greillier L, Le Caer H, Audigier-Valette C, Baize N, Berard H, Falchero L, Monnet I, Dansin E, Vergnenegre A, Marcq M, Decroisette C, Auliac JB, Bota S, Lamy R, Massuti B, Dujon C, Perol M, Daures JP, Descourt R, Lena H, Plassot C, Chouaid C (2016) Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. J Clin Oncol 34(13):1476–1483CrossRefPubMedGoogle Scholar
  8. de Oliveira PI, Pereira CA, Belasco AG, Bettencourt AR (2013) Comparison of the quality of life among persons with lung cancer, before and after the chemotherapy treatment. Rev Lat Am Enfermagem 21:787–794CrossRefPubMedGoogle Scholar
  9. Dela Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32(4):605–644CrossRefGoogle Scholar
  10. Didkowska J, Wojciechowska U, Manczuk M, Lobaszewski J (2016) Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med 4:150CrossRefPubMedPubMedCentralGoogle Scholar
  11. Griebsch I, Palmer M, Fayers PM, Ellis S (2014) Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib. BMJ Open 4:e005762CrossRefPubMedPubMedCentralGoogle Scholar
  12. Gupta D, Braun DP, Staren ED (2012) Association between changes in quality of life scores and survival in non-small cell lung cancer patients. Eur J Cancer Care (Engl) 21(5):614–622CrossRefGoogle Scholar
  13. Henoch I, Bergman B, Gustafsson M, Gaston-Johansson F, Danielson E (2007) The impact of symptoms, coping capacity, and social support on quality of life experience over time in patients with lung cancer. J Pain Symptom Manag 34(4):370–379CrossRefGoogle Scholar
  14. Larsson M, Ljung L, Johansson BB (2012) Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data. Eur J Cancer Care (Engl) 21:642–649CrossRefGoogle Scholar
  15. Leduc C, Quoix E (2016) Is there really a role for the comprehensive geriatric assessment in metastatic non-small cell lung cancer? Transl Cancer Res 5(Suppl 1):S44–S46CrossRefGoogle Scholar
  16. Li TC, Li CI, Tseng CH, Lin KS, Yang SY, Chen CY, Hsia TC, Lee YD, Lin CC (2012) Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health 12:790CrossRefPubMedPubMedCentralGoogle Scholar
  17. Li XH, Zhu JL, Hong C, Zeng L, Deng LM, Jin LY (2013) Effects of systematic rehabilitation programs on quality of life in patients undergoing lung resection. Mol Clin Oncol 1(1):200–208CrossRefPubMedGoogle Scholar
  18. Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF, Bartetto O, Novello S, Migliorino MR (2005) Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23(28):6865–6872CrossRefPubMedGoogle Scholar
  19. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR (2003) How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. Qual Life Res 12(2):157–166CrossRefPubMedGoogle Scholar
  20. Ngeow J, Leong SS, Gao F, Toh CK, Lim WT, Tan EH, Poon D (2010) Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status. Crit Rev Oncol Hematol 76(1):53–60CrossRefPubMedGoogle Scholar
  21. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMedGoogle Scholar
  22. Rauma V, Sintonen H, Rasanen JV, Salo JA, Ilonen IK (2015) Long-term lung cancer survivors have permanently decreased quality of life after surgery. Clin Lung Cancer 16(1):40–45CrossRefPubMedGoogle Scholar
  23. Rauma V, Salo J, Sintonen H, Rasanen J, Ilonen I (2016) Patient features predicting long-term survival and health-related quality of life after radical surgery for non-small cell lung cancer. Thorac Cancer 7(3):333–339CrossRefPubMedPubMedCentralGoogle Scholar
  24. Ridge CA, McErlean AM, Ginsberg MS (2013) Epidemiology of lung cancer. Semin Interv Radiol 30(2):93–98CrossRefGoogle Scholar
  25. Scott NW, Fayers PM, Aaronson NK, Bottoley A, de Greaff A, Groenvold M, Gundy C, Koller M, Pettersen MA, Sprangers MA (2008) EORTC QLQ-C30 reference values. Accessed on 27 Sept 2016
  26. Tomaszewski KA, Puskulluoglu M, Biesiada K, Bochenek J, Nieckula J, Krzemieniecki K (2013) Validation of the Polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer. J Psychosoc Oncol 31(2):191–203CrossRefPubMedGoogle Scholar
  27. Ubels RJ, Mokhles S, Andrinopoulou ER, Braat C, van der Voort van Zyp NC, Aluwini S, Aerts JG, Nuyttens JJ (2015) Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer. Radiat Oncol 10:98CrossRefPubMedPubMedCentralGoogle Scholar
  28. Wang JW, Gong XH, Ding N, Chen XF, Sun L, Tang Z, Yu DH, Yuan ZP, Wang XD, Yu JM (2015) The influence of comorbid chronic diseases and physical activity on quality of life in lung cancer survivors. Support Care Cancer 23(5):1383–1389CrossRefPubMedGoogle Scholar
  29. Yun YH, Kim YA, Sim JA, Shin AS, Chang YJ, Lee J, Kim MS, Shim YM, Zo JL (2016) Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer. BMC Cancer 16:505CrossRefPubMedPubMedCentralGoogle Scholar
  30. Zikos E, Ghislain I, Coens C, Ediebah DE, Sloan E, Quinten C, Koller M, van Meerbeeck JP, Flechtner HH, Stupp R, Pallis A, Czimbalmos A, Sprangers MA, Bottomley A (2014) Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials. Lancet Oncol 15(2):e78–e89CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Mariusz Chabowski
    • 1
    Email author
  • Jacek Polański
    • 2
  • Grzegorz Mazur
    • 3
  • Dariusz Janczak
    • 1
  • Joanna Rosińczuk
    • 4
  1. 1.Division of Surgical Procedures, Department of Clinical Nursing, Faculty of Health ScienceWroclaw Medical UniversityWroclawPoland
  2. 2.Lower Silesian Oncology Center, Home HospiceWroclawPoland
  3. 3.Department of Internal Medicine, Occupational Diseases, Hypertension and Clinical OncologyWroclaw Medical UniversityWroclawPoland
  4. 4.Department of Nervous System Diseases, Department of Clinical Nursing, Faculty of Health ScienceWroclaw Medical UniversityWroclawPoland

Personalised recommendations